ArticleOdontology2026
KeratoDynamics of transdifferentiation and dyskeratosis in odontogenic keratocysts.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Odontogenic keratocysts (OKCs) exhibit paradoxical biological behavior, displaying both cystic architecture and neoplastic potential. Their recurrence and local aggressiveness are believed to stem from epithelial plasticity and aberrant keratinization. This study introduces the concept of KeratoDynamics, a molecular framework integrating the processes of transdifferentiation and dyskeratosis in OKCs, through the analysis of three key biomarkers-Ki-67, c-Myc, and CK19. Formalin-fixed, paraffin-embedded samples of recurrent and non-recurrent OKCs were examined histologically and immunohistochemically. Quantitative assessment revealed significantly higher Ki-67 (42%) and c-Myc (38%) expression in recurrent lesions compared with non-recurrent cases (25% and 20%, respectively; p < 0.05). CK19 exhibited diffuse cytoplasmic positivity, with greater intensity in recurrent OKCs, indicating disrupted epithelial differentiation. A strong correlation between Ki-67 and c-Myc (r = 0.68, p < 0.01) reflected a proliferative-transcriptional coupling, while CK19 expression correlated moderately with delayed recurrence (r = 0.52, p < 0.05). Histologically, recurrent lesions demonstrated epithelial budding, dyskeratosis, and focal thickening, consistent with molecular reprogramming and epithelial instability. The collective expression of these markers defines the KeratoDynamics panel, which encapsulates the continuum between proliferation, lineage reprogramming, and keratinization that underlies OKC pathogenesis. This integrative approach enhances diagnostic precision, aids in recurrence prediction, and offers new perspectives for biologically guided management of odontogenic keratocysts.
Indexed as
Identifiers
41703372What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.